PMID: 9176017May 1, 1997Paper

Serum levels of vascular endothelial growth factor in patients with acute myocardial infarction undergoing reperfusion therapy

Clinical Science
Y SekoY Yazaki

Abstract

1. Vascular endothelial growth factor, a potent angiogenic mitogen, is known to be induced in response to ischaemia as well as being secreted from tumour cells. However, the precise mechanism of vascular endothelial growth factor release in acute myocardial infarction and the effects of coronary reperfusion on the circulating levels of vascular endothelial growth factor are still unknown. 2. Nineteen patients with acute myocardial infarction who underwent early reperfusion therapy were studied. Serum levels of vascular endothelial growth factor before reperfusion were markedly increased as compared with those in 19 healthy control subjects [252.4 +/- 158.1 pg/ml (mean +/- SD) compared with undetectable]. After reperfusion, the serum vascular endothelial growth factor levels rapidly returned almost completely to the normal control range. 4. These data strongly suggest that the serum level of vascular endothelial growth factor is one of the most sensitive indicators of myocardial ischaemia.

Citations

Oct 26, 2005·Cell Communication & Adhesion·Rune SundsetKirsti Ytrehus
Dec 15, 2005·Scandinavian Cardiovascular Journal : SCJ·Tsung-Hsien LinSheng-Hsiung Sheu
Nov 24, 2005·The Kaohsiung Journal of Medical Sciences·Tsung-Hsien LinSheng-Hsiung Sheu
May 20, 2008·Cardiovascular Revascularization Medicine : Including Molecular Interventions·Yasar KucukardaliAydogan Aydogdu
Feb 24, 2007·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·Ioannis BougioukasGeorgios Bougioukas
Dec 18, 2007·British Journal of Pharmacology·M CiccarelliG Iaccarino
Aug 3, 2005·International Journal of Cardiology·Jochen Müller-EhmsenRobert H G Schwinger
Mar 25, 2000·Journal of the American College of Cardiology·Y HojoK Shimada
Mar 1, 2000·The Journal of Thoracic and Cardiovascular Surgery·S L StarnesF M Lupinetti
Oct 8, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Kazuhiro TakahashiHirofumi Hamada
May 25, 2007·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Dario LeoscoFranco Rengo
Jun 19, 2002·American Journal of Respiratory and Critical Care Medicine·Lena LaviePeretz Lavie
Apr 6, 2002·Circulation Research·Rhea C PimentelJeffrey E Saffitz
Nov 13, 2008·Journal of Cardiovascular Medicine·Ugo TestaGian Luigi Condorelli
Nov 24, 2001·American Journal of Respiratory and Critical Care Medicine·D R ThickettA B Millar
Nov 13, 2001·American Journal of Physiology. Lung Cellular and Molecular Physiology·P M BeckerJ G Garcia
Nov 7, 2002·Circulation Journal : Official Journal of the Japanese Circulation Society·Takeshi SoekiNobuo Fukuda
Jun 27, 2003·Coronary Artery Disease·Hiroshi SuzukiTakashi Katagiri
Jan 27, 1999·Biochemical and Biophysical Research Communications·Y SekoY Yazaki
Jul 27, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P B VermeulenL Y Dirix

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.